Document Detail

De Vega's annuloplasty for acquired tricuspid disease: early and late results in 110 patients.
MedLine Citation:
PMID:  2818058     Owner:  NLM     Status:  MEDLINE    
From January 1978 through February 1989, 110 tricuspid annuloplasties (De Vega's procedure) were performed in association with mitral and combined mitral and aortic valve disease. Preoperatively, 106 (96%) of 110 patients were in New York Heart Association functional class III or IV. There were seven early deaths (6.3%), and 3 patients, 2 with mitral lesions and 1 with a combined lesion, died during a follow-up period of 3 to 52 months (mean follow-up, 22 months). Four patients (3.6%) required reoperation because of biological mitral valve failure at 5 to 8 years after tricuspid annuloplasty (mean period, 6.6 years). Twenty-three (62%) of 37 randomly selected patients evaluated by echocardiography and 14 (70%) of 20 patients evaluated by right ventriculography showed complete disappearance of tricuspid regurgitation after tricuspid annuloplasty in 1 to 18 months (mean period, 3.3 months). Seventy-seven (96%) of the survivors were in functional class I or II after tricuspid annuloplasty. The actuarial survival rate for the TAP series including early deaths was 85.8% +/- 7.4% at 10 years and the actuarial rate of freedom from reoperation on the tricuspid valve was 96.7% +/- 1.4%. Our surgical experience indicates that the De Vega's annuloplasty, as the method of first choice, is a simple, reliable procedure and resulted in improvement in 90% of patients with moderate to severe functional tricuspid regurgitation.
T Abe; M Tukamoto; M Yanagiya; M Morikawa; N Watanabe; S Komatsu
Related Documents :
10426848 - Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy.
9892588 - Doppler-derived mitral deceleration time: an early strong predictor of left ventricular...
19419498 - Preoperative management for tricuspid regurgitation in hypoplastic left heart syndrome.
20598968 - The everest ii trial: design and rationale for a randomized study of the evalve mitracl...
16082578 - Percutaneous closure of perimembranous ventricular septal defects with the eccentric am...
20201178 - Management of stone disease: 17 years experience of a stone clinic in a developing coun...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  48     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1989-12-18     Completed Date:  1989-12-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  670-6     Citation Subset:  AIM; IM    
Department of Thoracic and Cardiovascular Surgery, Sapporo Medical College, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Echocardiography, Doppler
Follow-Up Studies
Middle Aged
Postoperative Complications / mortality
Time Factors
Tricuspid Valve / surgery
Tricuspid Valve Insufficiency / surgery*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplanta...
Next Document:  Replacement of the esophagus by a segment of colon provided with an antireflux valve.